Ads
related to: immunosuppressants after kidney transplant patients- What Is PH1?
Learn about primary hyperoxaluria
type 1, and a treatment option.
- Treatment Option
Discover an FDA-approved treatment
for PH1 in children and adults.
- Sign Up for Updates
Sign up to receive important
updates on PH1 and a PH1 treatment.
- Patient Education Liaison
Ask an Alnylam educator your
questions on a treatment for PH1.
- What Is PH1?
Search results
Results From The WOW.Com Content Network
Calcineurin inhibitors and azathioprine have been linked with post-transplant malignancies and skin cancers in organ transplant recipients. Non-melanoma skin cancer (NMSC) after kidney transplantation is common and can result in significant morbidity and mortality. The results of several studies suggest that calcineurin inhibitors have ...
Thymoglobulin and Atgam are currently licensed for use in the treatment of renal allograft rejection; Atgam is additionally licensed for use in the treatment of aplastic anemia. Both drugs are used in off-label applications, especially as immunosuppression induction agents before and/or during kidney transplantation.
Muromonab-CD3 (brand name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant medication given to reduce acute rejection in people with organ transplants. [1] [2] It is a monoclonal antibody targeted at the CD3 receptor, [3] a membrane protein on the surface of T cells.
Mycophenolic acid is an immunosuppressant medication used to prevent rejection following organ transplantation and to treat autoimmune conditions such as Crohn's disease and lupus. [12] [13] Specifically it is used following kidney, heart, and liver transplantation. [13] It can be given by mouth or by injection into a vein. [13]
Thymoglobulin (manufactured by Sanofi) is an anti-human thymocyte immunoglobulin preparation made of purified polyclonal antibodies derived from rabbits.While these antibodies have a variety of specificities, their main mechanism of immunosuppression is through depletion of T cells.
In general, deliberately induced immunosuppression is performed to prevent the body from rejecting an organ transplant. [3] Additionally, it is used for treating graft-versus-host disease after a bone marrow transplant , or for the treatment of auto-immune diseases such as systemic lupus erythematosus , rheumatoid arthritis , Sjögren's ...
Tacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug.After allogenic organ transplant, the risk of organ rejection is moderate. To lower the risk of organ rejection, tacrolimus is given.
In transplant patients, skin cancer is 50 to 250 times more common than in the general population, and between 60 and 90% of patients are affected 20 years after transplantation. The use of immunosuppressive medication including azathioprine in organ transplantation has been linked to increased rates of developing skin cancer. [51]